Entero Healthcare Builds Scale in Pharma Distribution

Entero Healthcare Solutions (

) is building a large healthcare distribution and supply-chain platform, connecting pharmaceutical manufacturers with hospitals, pharmacies and other healthcare providers. The company is now attracting institutional attention. 3P Investment Managers, owned by Prashant Jain, acquired a 2.5% stake in Entero through open-market transactions on August 24, 2026, after which the stock gained around 15% over two sessions. The more interesting part is the underlying business model. Entero operates across pharmaceutical distribution and healthcare supply chains, where scale can improve purchasing, inventory management and distribution efficiency. Its Q1 FY27 performance also showed continued business expansion, making the combination of operating scale and increasing investor interest worth tracking. The stock is therefore interesting not simply because a well-known investor bought it, but because the investment brings attention to a relatively under-discussed part of India's healthcare ecosystem: the infrastructure that moves medicines from manufacturers to the end customer.